Press Releases

Company press releases and official corporate announcements.

A centralized feed of corporate press releases, earnings announcements, mergers, and official statements. Content is presented for informational purposes and may require additional analysis for market relevance.

Articles

6,777 total articles

Assembly Biosciences Highlights Presentations on Positive Phase 1b Data for ABI-5366 and ABI-1179 in Recurrent Genital Herpes at ESCMID Global 2026

Assembly Biosciences Highlights Presentations on Positive Phase 1b Data for ABI-5366 and ABI-1179 in Recurrent Genital Herpes at ESCMID Global 2026

Assembly Biosciences reported encouraging Phase 1b data for its investigational long-acting herpes simplex virus (HSV) helicase-primase inhibitors ABI-5366 and ABI-1179. The data, highlighting safety, tolerability, and potential efficacy in treating recurrent genital herpes, will be presented at the ESCMID 2026 conference. These drug candidates are…

OwlTing Group (NASDAQ: OWLS) Expands Visa Collaboration to Support U.S. Debit Card Funding of USDC Transactions

OwlTing Group (NASDAQ: OWLS) Expands Visa Collaboration to Support U.S. Debit Card Funding of USDC Transactions

OwlTing Group (NASDAQ: OWLS) has expanded its partnership with Visa to integrate Visa Direct into its OwlPay payment infrastructure. This integration allows U.S. consumers to fund USDC digital currency transactions directly via their Visa debit cards, streamlining access to digital assets without needing dedicated exchange accounts. This enhancemen…

Zentalis Pharmaceuticals Announces 400mg QD 5:2 Azenosertib Monotherapy as the Pivotal Study Dose in Cyclin E1-Positive Platinum-Resistant Ovarian Cancer

Zentalis Pharmaceuticals Announces 400mg QD 5:2 Azenosertib Monotherapy as the Pivotal Study Dose in Cyclin E1-Positive Platinum-Resistant Ovarian Cancer

Zentalis Pharmaceuticals announced the selection of the 400mg once daily on a 5-days-on, 2-days-off dosing regimen of their investigational drug azenosertib for use in Cyclin E1-positive platinum-resistant ovarian cancer. The decision is based on positive interim data from the DENALI Part 2a Phase 2 clinical trial showing improved response rates at…

Trident Digital Tech Partners with Israel’s Cybersecurity Leading Firm Memcyco to Launch Asia-Pacific’s First Preemptive AI Fraud Defense

Trident Digital Tech Partners with Israel’s Cybersecurity Leading Firm Memcyco to Launch Asia-Pacific’s First Preemptive AI Fraud Defense

Trident Digital Tech Holdings Ltd (Nasdaq: TDTH) announced a strategic partnership with U.S.-Israeli cybersecurity firm Memcyco to launch the first AI-driven preemptive fraud defense solution in the Asia-Pacific region. The integrated solution combines Memcyco's real-time threat detection with Trident's blockchain-based identity platform, enabling …

Coherent Advances Silicon Carbide Thick Epitaxy Capabilities for High-Voltage AI Datacenter and Industrial Power Applications Up to 10kV

Coherent Advances Silicon Carbide Thick Epitaxy Capabilities for High-Voltage AI Datacenter and Industrial Power Applications Up to 10kV

Coherent Corp. announced advancements in silicon carbide thick epitaxy capabilities, enabling production of power devices supporting voltages up to 10kV, aimed at enhancing efficiency and power density in next-generation AI datacenters and various industrial power applications. This technological leap supports the growing demand for efficient high-…

Northern Technologies International Corporation Reports Financial Results for Second Quarter Fiscal 2026

Northern Technologies International Corporation Reports Financial Results for Second Quarter Fiscal 2026

Northern Technologies International Corporation reported its financial results for the second quarter of fiscal year 2026, with consolidated net sales rising 15.3% year-over-year to a record $22 million. Key growth drivers included an 72.1% increase in ZERUST® oil and gas sales, 18.5% growth in China operations, and 8.1% increase in Natur-Tec® prod…

Credit Acceptance Named 2026 USA Today Top Workplaces Award Winner

Credit Acceptance Named 2026 USA Today Top Workplaces Award Winner

Credit Acceptance Corporation has been named a 2026 USA Today Top Workplaces award winner for the sixth consecutive year, ranking #4 in its employee size category. The company is also recognized in the Well-Being specialty category, highlighting its commitment to employee engagement, remote work flexibility, and a positive workplace culture. This f…

Perpetuals.com Launches Strategic Initiative to Deploy Next-Generation Agentic AI Infrastructure Platform for Fintech and Digital Assets Industry; Secures Exclusive License for Proprietary On-Premises Quantitative Research Platform "Forgentiq.ai"

Perpetuals.com Launches Strategic Initiative to Deploy Next-Generation Agentic AI Infrastructure Platform for Fintech and Digital Assets Industry; Secures Exclusive License for Proprietary On-Premises Quantitative Research Platform "Forgentiq.ai"

Perpetuals.com Ltd announced a strategic initiative to license and deploy Forgentiq.ai, an exclusive on-premises agentic AI platform tailored for hedge funds, proprietary trading firms, and digital asset managers. The platform focuses on data sovereignty by operating within clients' secure environments, enabling advanced quantitative research and t…

Cardiff Oncology Announces Key Leadership Appointments to Strengthen Executive Team for Next Phase of Growth

Cardiff Oncology Announces Key Leadership Appointments to Strengthen Executive Team for Next Phase of Growth

Cardiff Oncology, a clinical-stage biotech company developing PLK1 inhibitors for cancer treatment, announced key executive appointments to support its next growth phase. Mani Mohindru, PhD, was named President and CEO after serving as Interim CEO. Industry veterans Josh Muntner and Ajay Aggarwal, MD, MBA, joined as CFO and COO, respectively. These…

Seer and Precision Health Research, Singapore Sign Collaboration to Provide Deep, Unbiased Proteomics on 10,000 PRECISE SG100K Samples

Seer and Precision Health Research, Singapore Sign Collaboration to Provide Deep, Unbiased Proteomics on 10,000 PRECISE SG100K Samples

Seer, Inc. announced that its Proteograph Product Suite was selected to provide deep, unbiased proteomic profiling for 10,000 participants in Singapore's PRECISE-SG100K multi-ancestry cohort study. Integrating proteomics data with genomics and other health data, this collaboration aims to advance precision medicine and biomarker validation in diver…